Revenue - Textuals (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | |||
Revenue related to licenses granted to collaboration partners | $ 290,900 | ||
Recognition of deferred revenue | (1,496) | $ (4,119) | $ (3,996) |
Deferred Credits and Other Liabilities | 4,300 | ||
2017 Roche | |||
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | |||
Development milestones | 37,000 | ||
OtherCollaborators | |||
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | |||
Deferred revenues | 81,700 | ||
License fees and event-based payments | |||
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | |||
Recognition of deferred revenue | (1,500) | ||
Product sales, net | |||
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | |||
Deferred Credits and Other Liabilities, Current | $ 77,400 |